[HTML] plos.org

[HTML][HTML] Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation

L Gao, J Schwartzman, A Gibbs, R Lisac… - PloS one, 2013 - journals.plos.org
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …
被引用次数：146 相关文章

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

L Gao, J Schwartzman, A Gibbs, R Lisac… - PLoS ONE, 2013 - go.gale.com
Prostate cancer is the most common cancer in men in the United States with 241,740 new
cases anticipated this year [1]. Despite screening and early treatment, prostate cancer …

Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.

L Gao, J Schwartzman, A Gibbs, R Lisac… - Plos one, 2013 - europepmc.org
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …

[引用][C] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

L Gao, J Schwartzman, A Gibbs, R Lisac… - PLoS …, 2013 - ui.adsabs.harvard.edu
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc
Upregulation - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …
[PDF] researchgate.net

[PDF][PDF] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression

L Gao, J Schwartzman, A Gibbs, R Lisac… - 2013 - researchgate.net
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …
[PDF] academia.edu

[PDF][PDF] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression

L Gao, J Schwartzman, A Gibbs, R Lisac… - 2013 - academia.edu
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …
[PDF] psu.edu

[PDF][PDF] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression

L Gao, J Schwartzman, A Gibbs, R Lisac… - 2013 - Citeseer
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …
[PDF] cyberleninka.org

[PDF][PDF] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression

L Gao, J Schwartzman, A Gibbs, R Lisac… - 2013 - cyberleninka.org
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

L Gao, J Schwartzman, A Gibbs, R Lisac… - PLoS …, 2013 - search.ebscohost.com
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …
[HTML] nih.gov

[HTML][HTML] Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation

L Gao, J Schwartzman, A Gibbs, R Lisac… - PLoS ONE, 2013 - ncbi.nlm.nih.gov
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the
past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus …